IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings

Diabetologia

Volumn 40, Issue 1, 1997, Pages 95-99

  Gorus, F K ^a,b   Goubert, P ^a,b   Semakula, C ^a   Vandewalle, C L ^a   De Schepper, J ^b   Scheen, A ^c   Christie, M R ^d   Pipeleers, D G ^a  

^a DIABETES RESEARCH CENTER   (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^c UNIVERSITY OF LIÈGE   (Belgium)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

autoantibodies; diabetes prediction; genetic susceptibility; insulin dependent diabetes mellitus; protein tyrosine phosphatases

Indexed keywords

AUTOANTIBODY; INSULIN ANTIBODY; PROTEIN TYROSINE PHOSPHATASE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; GENETIC SUSCEPTIBILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE OF ONSET; AUTOANTIBODIES; BELGIUM; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; GLUTAMATE DECARBOXYLASE; HLA-D ANTIGENS; HUMANS; ISLETS OF LANGERHANS; MALE; NUCLEAR FAMILY; PREVALENCE;

EID: 0031013039     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050648     Document Type: Article

References (10)

1. Lu J, Li Q, Xie H et al. (1996) Identification of a second transmembrane tyrosine phosphatase, IA-2β, as an autoantigen in insulin-dependent diabetes: precursor of the 37-kDa tryptic fragment. Proc Natl Acad Sci USA 93: 2307-2311
2. Payton MA, Hawkes CJ, Christie MR (1995) Relationship of the 37,000- and 47,000 Mr tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA 512). J Clin Invest 96: 1506-1511
3. -2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40 k autoantigen and a target of islet-cell antibodies. J Immunol 155: 5419-5426
4. Myers MA, Rabin DU, Rowley MJ (1995) Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase. Diabetes 44: 1290-1295
5. Van der Auwera B, Schuit F, Lyaruu I et al. (1995) Genetic susceptibility for insulin-dependent diabetes mellitus in Caucasians revisited: the importance of diabetes registries in disclosing interactions between HLA-DQ- and insulin-gene-linked risk. J Clin Endocrinol Metab 80: 2567-2573
6. Zweig M, Campbell G (1993) Receiver-operating characteristics (ROC) plots: a fundamental tool in clinical medicine. Clin Chem 39: 561-571
7. Nisticò L, Buzzetti R, Pritchard LE et al. (1996) The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Hum Mol Genet 5: 1075-1080
8. Morgenthaler NG, Seissler J, Achenbach P et al. (1996) Antibodies to IA-2 in IDDM, Stiff man syndrome and autoimmune endocrine diseases: evidence of high specificity for IDDM. Diabetologia 39 [Suppl I]: A27 (Abstract)
9. 65-Autoantibodies are associated with HLA-DQ- and 5′INS-linked genetic risk in adult new onset IDDM-patients. Autoimmunity 21: 31 (A119)
10. Verge CF, Gianani R, Kawasaki E et al. (1996) Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD, and ICA 512 bdc/IA-2 autoantibodies. Diabetes 45: 926-933